"It is currently unclear how useful the Labcorp test will be in accurately ... patient predicted to have preeclampsia from a blood test early in pregnancy as opposed to clinical factors," Zahn ...
Looking back on testing & diagnostics services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, ...
Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth testing areas.
The test, which utilizes circulating tumor DNA (ctDNA) from a blood draw, is intended to help oncologists tailor personalized treatment plans. According to InvestingPro analysis, Labcorp maintains ...
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood ...
Burlington, North Carolina-based Labcorp Holdings Inc. (LH) is a provider of laboratory services. It offers various tests, such as blood chemistry analyses, urinalyses, thyroid, PAP, substance ...
With over 600 million tests performed annually and involvement in 90% of FDA-approved drugs in 2023, Labcorp (NYSE:LH) provides laboratory testing services and drug development solutions to ...